
1. aids. 2018 nov 13;32(17):2605-2614. doi: 10.1097/qad.0000000000002010.

cd4+ cell count recovery combined antiretroviral therapy modern
combined antiretroviral therapy era.

roul h(1), mary-krause m(1), ghosn j(2), delaugerre c(3), pialoux g(4), cuzin
l(5), launay o(6), lacombe jm(7), menard a(8), de truchis p(9), delfraissy
jf(10), weiss l(11), costagliola d(1); fhdh-anrs co4.

author information: 
(1)inserm, sorbonne université, institut pierre louis d'epidémiologie et de santé
publique.
(2)aphp, service des maladies infectieuses et tropicales, hôpitaux universitaires
paris nord site bichat-claude bernard, université paris diderot, inserm u 1137
iame, pres sorbonne paris-cité.
(3)aphp, service de virologie, hôpital st louis, université paris diderot.
(4)aphp, service des maladies infectieuses et tropicales, hôpital tenon,
université paris descartes, sorbonne paris-cité, paris.
(5)umr1027, université de toulouse, ups, inserm, toulouse, service des maladies
infectieuses et tropicales, chu de la martinique, fort de france.
(6)aphp, hôpital cochin, université paris descartes, sorbonne paris-cité.
(7)inserm, sorbonne université, institut pierre louis d'epidémiologie et de santé
publique, inserm transfert, paris.
(8)institut hospitalo-universitaire (ihu) - méditerranée infection, marseille.
(9)infectious disease departement, aphp, hôpital raymond poincaré, garches.
(10)aphp, hôpital bicêtre, le kremlin-bicêtre.
(11)aphp, hôpital européen george pompidou, université paris descartes, sorbonne 
paris-cité, paris, france.

objective: assess cd4 recovery combined antiretroviral therapy (cart)
initiation sustained virologic control.
design: cohort study based french hospital database hiv (fhdh-anrs
co4).
methods: selected naive hiv-1-infected individuals initiating cart between
2006 2014 cd4 cell counts less 500 cells/μl achieved virologic 
control, defined two consecutive viral loads less 50 copies/ml. we
estimated cumulative incidence cd4 recovery least 500 cells/μl and
identified associated factors, considering 'virologic failure,' 'loss to
follow-up' 'death' competing events.
results: analyzed 6050 individuals median follow-up 14.2 months
since virologic control. cumulative incidence cd4 recovery 6 years 
of virologic control reached 69.7%. main factor associated cd4 recovery 
was cd4 count treatment initiation [subdistribution hazard ratio (shr)
9.64, 95% confidence interval (95% ci) 8.12-11.43 cd4 cell counts 350
and 500 cells/μl compared cd4 cell counts <100 cells/μl). higher cd4/cd8
ratio initiation also independently associated higher probability
of cd4 recovery [shr 1.67; 95% ci 1.34-2.09] cd4/cd8 ratio ≥1.00 vs. <
0.30). higher viral load initiation also associated higher
probability cd4 recovery, whereas time viral suppression not.
conclusion: 6 years sustained virologic control, large majority the
population achieved cd4 recovery. higher cd4 cell count initiation a
strong predictor cd4 recovery and, lesser extent, higher cd4/cd8 ratio 
at initiation. results confirm necessity early treatment.

doi: 10.1097/qad.0000000000002010 
pmid: 30289817  [indexed medline]

